GCM
TBPH icon

Graham Capital Management’s Theravance Biopharma TBPH Stock Holding History

Graham Capital Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,296
Closed -$193K – 1509
2025
Q4 		$193K Sell
10,296
-5,815
-36% -$96.5K 0.01% 1055
2025
Q3 		$235K Sell
16,111
-3,261
-17% -$41.2K 0.01% 974
2025
Q2 		$214K Sell
19,372
-5,582
-22% -$54.3K 0.01% 1108
2025
Q1 		$223K Sell
24,954
-11,410
-31% -$106K 0.01% 1102
2024
Q4 		$342K Buy
36,364
+5,608
+18% +$51K 0.01% 877
2024
Q3 		$248K Buy
30,756
+2,197
+8% +$19K 0.01% 852
2024
Q2 		$242K Buy
28,559
+12,206
+75% +$110K 0.01% 795
2024
Q1 		$147K Buy
+16,353
New +$152K ﹤0.01% 931
2023
Q3 		– Sell
-14,662
Closed -$152K – 1291
2023
Q2 		$152K Sell
14,662
-3,268
-18% -$36.1K 0.01% 854
2023
Q1 		$195K Buy
+17,930
New +$190K 0.01% 969

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.1B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return